first company to have cbd products listed in u s physicians desk reference

Latest News

Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Direct Sales Veteran Eric Glenn as Entrepreneur

SUBSCRIBE AND GET THE LATES NEWS

* indicates required

First Name

Last Name

Email Address *

Follow us on

social networks

Home Company Investors Careers Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

first company to have cbd products listed in u s physicians desk reference

Latest News

POPULAR

SUBSCRIBE AND GET THE LATES NEWS